AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Passage Bio, Inc.
$5
-$6.69 (-57.23%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$4.99
Day Range
$4.9$5.24
Year Range
$3.29$20
Market Cap
16.06M
AVG Volume
63.23K
Trailing/Forward PE
-0.44/-
PEG ratio
-0.1
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQ
Video analysis: PASG
All videosNo video analysis for this stock yet. Request one from our team.
News: PASG
Passage Bio, Inc. (PASG) M&A Call Prepared Remarks Transcript
Passage Bio, Inc. (PASG) M&A Call Prepared Remarks Transcript
Passage Bio and Remix Therapeutics Announce Merger Agreement
Combined company to operate as Remix Therapeutics and advance Remix's pipeline of novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin
